Chlamydophila pneumoniae – biotyp TWAR – wybrane dane Chlamydophila pneumoniae biotype TWAR: selected details
نویسندگان
چکیده
منابع مشابه
Community-acquired pneumonia by Chlamydophila pneumoniae: a clinical and incidence study in Brazil.
As there was not any data on Chlamydia pneumoniae (TWAR) infections in Brazil so far, a prospective cohort study of adult patients hospitalized due to CAP was carried out for one year in a Brazilian university general hospital to detect the incidence of CAP by Chlamydophila pneumoniae (TWAR) for one year. During a whole year 645 consecutive patients hospitalized due to an initial presumptive di...
متن کاملA new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.
Chlamydia pneumoniae strain TWAR, the new third species of Chlamydia, is a common cause of pneumonia and other acute respiratory tract infections. About 10% of hospitalized and outpatient pneumonia cases have been associated with TWAR infection. TWAR is among the four or five most commonly identified causes of all pneumonia. Most TWAR infections are mild or asymptomatic, but occasionally severe...
متن کاملChlamydia pneumoniae, strain TWAR.
A new third species of Chiamydia, called C pneumoniae, has been established for the TWAR organism. We first thought that the new organism belonged to the C psittaci species because it was clearly not a C trachomatis.2’8 Subsequent studies showed that the organism was unique from both currently recognized species.8”#{176}”7”9 Justification for establishing a new species rests primarily on studie...
متن کاملIn vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.
متن کاملPrevalence of antibody to Chlamydia pneumoniae TWAR in japan.
Chlamydia pneumoniae TWAR is a newly recognized Chlamydia species that is a pathogen of respiratory tract infection. To clarify the endemic status of C. pneumoniae in Japan, we evaluated the incidence of C. pneumoniae antibody in 1,330 serum samples (660 from outpatients, 600 from normal individuals, and 70 from cord blood). The antibody titer was determined by a microimmunofluorescence test by...
متن کامل